Apple's Jobs Had Liver Transplant: Report

Stock quotes in this article:AAPL 

Apple(AAPL) CEO Steve Jobs, whose health has been of major concern to the company's investors, underwent a liver transplant about two months ago, according to a published media report.

The Apple co-founder, who has been on medical leave since January, had the transplant in Tennessee and is expected to return to work as scheduled later this month, although he may begin with a part-time schedule, said the report, which The Wall Street Journal published Saturday on its Web site.

When Jobs went on leave, he didn't disclose his specific health condition, although he is a pancreatic cancer survivor.

Jobs didn't respond to an email request for comment, the Journal reported. The newspaper quoted an Apple spokeswoman saying, "Steve continues to look forward to returning at the end of June, and there's nothing further to say."

Jobs, who in the 1990s returned to the company he had founded, is credited as the mastermind behind Apple's resurgence. Investors have worried for some time about his health, fearing that there is no successor capable of filling his shoes should he die or have to leave the company permanently.

Apple shares closed Friday at $139.48, up $3.60 or 2.65%.

>To order reprints of this article, click here: Reprints

This article was written by a staff member of TheStreet.com.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,801.23 1,342.64 2,903.88 19.69
Oil *
117.67
DOWN
89.23
DOWN
9.31
DOWN
23.35
DOWN
0.78
10 Yr
1.97%
SPDR Gold
167.14
-0.69%
-0.69%
-0.80%
-3.81%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet